RRML - Blood-based biomarkers in Alzheimer’s disease: an overview on proteomic and lipidomic approaches
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Română English


Journal Metrics

Impact Factor 0.5
Five Year Impact Factor 0.5
JCI 0.12


Advanced search


Top 10 downloaded articles
- June 2024 -
 
The evaluation of a diagnostic... 10
A comprehensive review of Prof... 9
Assessment of ocrelizumab impa... 7
Romanian Review of Laboratory ... 6
Monitoring the sensitivity of ... 6
Challenges in prophylactic the... 6
Diagnostic value of stress myo... 6
Effect of Systemic Inflammator... 5
Evaluation of routine laborato... 4
The role of nitro oxidative fa... 4

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 24(2)/2016 DOI:10.1515/rrlm-2016-0017
XML
TXT

Review

Blood-based biomarkers in Alzheimer’s disease: an overview on proteomic and lipidomic approaches

Geanina Andreea Ilinoiu, Raluca Tirintica, Cosmin Lungu, Adriana Mihai

Correspondence should be addressed to: Adriana Mihai

Abstract:

Alzheimer’s disease (AD) remains one of the most challenging pathologies since its etiology is not completely known, its progression is slow and there are no disease-changing pharmacological agents available yet. One other important characteristic is that the progression of AD pathology starts long before any symptoms are experienced by patients. This is where the need for early detection biomarkers comes from. Although there are biomarkers that have been intensely studied and are now included in research criteria, most of these biomarkers are either invasive or unaffordable. Blood-based biomarkers could be a viable alternative of accessible and acceptable biomarkers, and have been much studied in the past decade. Among them proteomics and lipidomics seem to be two most promising fields for biomarker development. The paper aims to offer an overview of developments in the field during the past 5 years highlighting the most promising biomarkers.

Keywords: blood biomarkers, Alzheimer’s disease, proteomics, lipidomics

Received: 16.11.2015
Accepted: 20.3.2016
Published: 28.4.2016

 
  PDF Download full text PDF
(419 KB)
     
 
How to cite
Ilinoiu GA, Tirintica R, Lungu C, Mihai A. Blood-based biomarkers in Alzheimer’s disease: an overview on proteomic and lipidomic approaches. Rev Romana Med Lab. 2016;24(2):143-52. DOI:10.1515/rrlm-2016-0017